Tubular aggregates in skeletal muscle: Just a special type of protein aggregates?

Neuromuscular Disorders

Volumn 22, Issue 3, 2012, Pages 199-207

  Schiaffino, Stefano ^a,b  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^b CNR   (Italy)

Author keywords

Myopathy; Protein aggregates; Proteostasis; Sarcoplasmic reticulum; Skeletal muscle; Tubular aggregates

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; AMYLOID BETA PROTEIN; CALSEQUESTRIN; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MEMBRANE PROTEIN; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ARTICLE; CELL INCLUSION; ENDOPLASMIC RETICULUM; GENE MUTATION; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; INCLUSION BODY MYOSITIS; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; MYOTONIC DYSTROPHY; NONHUMAN; PERIODIC PARALYSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; THOMSEN DISEASE; TUBULAR AGGREGATE;

ANIMALS; HUMANS; MALE; MICE; MICROSCOPY, ELECTRON; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; RATS; SARCOPLASMIC RETICULUM;

EID: 84858073981     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2011.10.005     Document Type: Article

References (63)

1. Engel W.K., Bishop D.W., Cunningham G.G. Tubular aggregates in type II muscle fibers: ultrastructural and histochemical correlation. J Ultrastruct Res 1970, 31:507-525.
2. Rosenberg N.L., Neville H.E., Ringel S.P. Tubular aggregates. Their association with neuromuscular diseases, including the syndrome of myalgias/cramps. Arch Neurol 1985, 42:973-976.
3. Niakan E., Harati Y., Danon M.J. Tubular aggregates: their association with myalgia. J Neurol Neurosurg Psychiatry 1985, 48:882-886.
4. Oh S.J., Park K.S., Ryan H.F., et al. Exercise-induced cramp, myoglobinuria, and tubular aggregates in phosphoglycerate mutase deficiency. Muscle Nerve 2006, 34:572-576.
5. Naini A., Toscano A., Musumeci O., Vissing J., Akman H.O., DiMauro S. Muscle phosphoglycerate mutase deficiency revisited. Arch Neurol 2009, 66:394-398.
6. Goebel H.H., Bonnemann C.G. 169th ENMC International Workshop Rare Structural Congenital Myopathies 6-8 November 2009, Naarden, The Netherlands. Neuromuscul Disord 2011, 21:363-374.
7. Cameron C.H., Allen I.V., Patterson V., Avaria M.A. Dominantly inherited tubular aggregate myopathy. J Pathol 1992, 168:397-403.
8. Pierobon-Bormioli S., Armani M., Ringel S.P., et al. Familial neuromuscular disease with tubular aggregates. Muscle Nerve 1985, 8:291-298.
9. Rohkamm R., Boxler K., Ricker K., Jerusalem F. A dominantly inherited myopathy with excessive tubular aggregates. Neurology 1983, 33:331-336.
10. Rodolico C., Toscano A., Autunno M., et al. Limb-girdle myasthenia: clinical, electrophysiological and morphological features in familial and autoimmune cases. Neuromuscul Disord 2002, 12:964-969.
11. Senderek J., Muller J.S., Dusl M., et al. Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am J Hum Genet 2011, 88:162-172.
12. Tulinius M.H., Lundberg A., Oldfors A. Early-onset myopathy with tubular aggregates. Pediatr Neurol 1996, 15:68-71.
13. Craig I.D., Allen I.V. Tubular aggregates in murine dystrophy heterozygotes. Muscle Nerve 1980, 3:134-140.
14. Steeghs K., Benders A., Oerlemans F., et al. Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell 1997, 89:93-103.
15. Amthor H., Macharia R., Navarrete R., et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 2007, 104:1835-1840.
16. Schubert W., Sotgia F., Cohen A.W., et al. Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation. Am J Pathol 2007, 170:316-333.
17. Agbulut O., Destombes J., Thiesson D., Butler-Browne G. Age-related appearance of tubular aggregates in the skeletal muscle of almost all male inbred mice. Histochem Cell Biol 2000, 114:477-481.
18. Chevessier F., Marty I., Paturneau-Jouas M., Hantai D., Verdiere-Sahuque M. Tubular aggregates are from whole sarcoplasmic reticulum origin: alterations in calcium binding protein expression in mouse skeletal muscle during aging. Neuromuscul Disord 2004, 14:208-216.
19. Kuncl R.W., Pestronk A., Lane J., Alexander E. The MRL +/+ mouse: a new model of tubular aggregates which are gender- and age-related. Acta Neuropathol 1989, 78:615-620.
20. Nishikawa T., Takahashi J.A., Matsushita T., et al. Tubular aggregates in the skeletal muscle of the senescence-accelerated mouse; SAM. Mech Ageing Dev 2000, 114:89-99.
21. Lahoute C., Sotiropoulos A., Favier M., et al. Premature aging in skeletal muscle lacking serum response factor. PLoS One 2008, 3:e3910.
22. Ludatscher R., Silbermann M., Gershon D., Reznick A. The effects of enforced running on the gastrocnemius muscle in aging mice: an ultrastructural study. Exp Gerontol 1983, 18:113-123.
23. Boncompagni S., Protasi F., Franzini-Armstrong C. Sequential stages in the age-dependent gradual formation and accumulation of tubular aggregates in fast twitch muscle fibers: SERCA and calsequestrin involvement. Age (Dordr) 2011.
24. Chevessier F., Bauche-Godard S., Leroy J.P., et al. The origin of tubular aggregates in human myopathies. J Pathol 2005, 207:313-323.
25. Salviati G., Pierobon-Bormioli S., Betto R., et al. Tubular aggregates: sarcoplasmic reticulum origin, calcium storage ability, and functional implications. Muscle Nerve 1985, 8:299-306.
26. Schiaffino S., Margreth A. Coordinated development of the sarcoplasmic reticulum and T system during postnatal differentiation of rat skeletal muscle. J Cell Biol 1969, 41:855-875.
27. Vissing J., Schmalbruch H., Haller R.G., Clausen T. Muscle phosphoglycerate mutase deficiency with tubular aggregates: effect of dantrolene. Ann Neurol 1999, 46:274-277.
28. Schiaffino S., Severin E., Cantini M., Sartore S. Tubular aggregates induced by anoxia in isolated rat skeletal muscle. Lab Invest 1977, 37:223-228.
29. Cookson M.R., Bandmann O. Parkinson's disease: insights from pathways. Hum Mol Genet 2010, 19:R21-R27.
30. Balch W.E., Morimoto R.I., Dillin A., Kelly J.W. Adapting proteostasis for disease intervention. Science 2008, 319:916-919.
31. Douglas P.M., Dillin A. Protein homeostasis and aging in neurodegeneration. J Cell Biol 2010, 190:719-729.
32. Askanas V., Engel W.K. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 2006, 66:S39-S48.
33. Mendell J.R., Sahenk Z., Gales T., Paul L. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch Neurol 1991, 48:1229-1234.
34. Selcen D. Myofibrillar myopathies. Neuromuscul Disord 2011, 21:161-171.
35. De Bleecker J.L., Engel A.G., Ertl B.B. Myofibrillar myopathy with abnormal foci of desmin positivity II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 1996, 55:563-577.
36. Roth D.M., Balch W.E. Modeling general proteostasis: proteome balance in health and disease. Curr Opin Cell Biol 2011, 23:126-134.
37. Muchowski P.J., Wacker J.L. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 2005, 6:11-22.
38. Luan X., Chen B., Liu Y., Zheng R., Zhang W., Yuan Y. Tubular aggregates in paralysis periodica paramyotonica with T704M mutation of SCN4A. Neuropathology 2009, 29:579-584.
39. Martin J.E., Mather K., Swash M., Gray A.B. Expression of heat shock protein epitopes in tubular aggregates. Muscle Nerve 1991, 14:219-225.
40. Chin D.J., Luskey K.L., Anderson R.G., Faust J.R., Goldstein J.L., Brown M.S. Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proc Natl Acad Sci USA 1982, 79:1185-1189.
41. Snapp E.L., Hegde R.S., Francolini M., et al. Formation of stacked ER cisternae by low affinity protein interactions. J Cell Biol 2003, 163:257-269.
42. Takei K., Mignery G.A., Mugnaini E., Sudhof T.C., De Camilli P. Inositol 1,4,5-trisphosphate receptor causes formation of ER cisternal stacks in transfected fibroblasts and in cerebellar Purkinje cells. Neuron 1994, 12:327-342.
43. Bagnato P., Barone V., Giacomello E., Rossi D., Sorrentino V. Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles. J Cell Biol 2003, 160:245-253.
44. Kontrogianni-Konstantopoulos A., Jones E.M., Van Rossum D.B., Bloch R.J. Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Mol Biol Cell 2003, 14:1138-1148.
45. Lange S., Ouyang K., Meyer G., et al. Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum. J Cell Sci 2009, 122:2640-2650.
46. Gokhin D.S., Fowler V.M. Cytoplasmic {gamma}-actin and tropomodulin isoforms link to the sarcoplasmic reticulum in skeletal muscle fibers. J Cell Biol 2011, 194:105-120.
47. Takekura H., Nishi M., Noda T., Takeshima H., Franzini-Armstrong C. Abnormal junctions between surface membrane and sarcoplasmic reticulum in skeletal muscle with a mutation targeted to the ryanodine receptor. Proc Natl Acad Sci USA 1995, 92:3381-3385.
48. Takeshima H., Komazaki S., Nishi M., Iino M., Kangawa K. Junctophilins: a novel family of junctional membrane complex proteins. Mol Cell 2000, 6:11-22.
49. Ito K., Komazaki S., Sasamoto K., et al. Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. The J Cell Biol 2001, 154:1059-1067.
50. Ko J.K., Choi K.H., Zhao X., et al. A versatile single-plasmid system for tissue-specific and inducible control of gene expression in transgenic mice. FASEB J 2011, 25:2638-2649.
51. Hirata Y., Brotto M., Weisleder N., et al. Uncoupling store-operated Ca2+ entry and altered Ca2+ release from sarcoplasmic reticulum through silencing of junctophilin genes. Biophys J 2006, 90:4418-4427.
52. Voeltz G.K., Prinz W.A., Shibata Y., Rist J.M., Rapoport T.A. A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 2006, 124:573-586.
53. Helenius A., Aebi M. Intracellular functions of N-linked glycans. Science 2001, 291:2364-2369.
54. Groenendyk J., Sreenivasaiah P.K., Kim do H., Agellon L.B., Michalak M. Biology of endoplasmic reticulum stress in the heart. Circ Res 2010, 107:1185-1197.
55. Muller J.S., Herczegfalvi A., Vilchez J.J., et al. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain 2007, 130:1497-1506.
56. Beard N.A., Laver D.R., Dulhunty A.F. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Progr Biophys Mol Biol 2004, 85:33-69.
57. Wells L., Vosseller K., Hart G.W. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science 2001, 291:2376-2378.
58. Ngoh G.A., Facundo H.T., Zafir A., Jones S.P. O-GlcNAc signaling in the cardiovascular system. Circ Res 2010, 107:171-185.
59. Luff A.R., Atwood H.L. Changes in the sarcoplasmic reticulum and transverse tubular system of fast and slow skeletal muscles of the mouse during postnatal development. The J Cell Biol 1971, 51:369-383.
60. Schiaffino S., Hanzlikova V., Pierobon S. Relations between structure and function in rat skeletal muscle fibers. J Cell Biol 1970, 47:107-119.
61. Badrising U.A., Maat-Schieman M., van Duinen S.G., et al. Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000, 55:1385-1387.
62. Hanada S., Snider N.T., Brunt E.M., Hollenberg P.F., Omary M.B. Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress. Gastroenterology 2010, 138:1607-1617.
63. Ghosh A., Narayanappa G., Taly A.B., et al. Tubular aggregate myopathy: a phenotypic spectrum and morphological study. Neurol India 2010, 58:747-751.